Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients.
Cantini L, Pecci F, Hurkmans DP, Belderbos RA, Lanese A, Copparoni C, Aerts S, Cornelissen R, Dumoulin DW, Fiordoliva I, Rinaldi S, Aerts JGJV, Berardi R. Cantini L, et al. Among authors: fiordoliva i. Eur J Cancer. 2021 Feb;144:41-48. doi: 10.1016/j.ejca.2020.10.031. Epub 2020 Dec 14. Eur J Cancer. 2021. PMID: 33326868
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis.
Cantini L, Merloni F, Rinaldi S, Lenci E, Marcantognini G, Meletani T, Fiordoliva I, Morgese F, Torniai M, Ricci G, Giampieri R, Berardi R. Cantini L, et al. Among authors: fiordoliva i. Crit Rev Oncol Hematol. 2020 Jul;151:102974. doi: 10.1016/j.critrevonc.2020.102974. Epub 2020 May 4. Crit Rev Oncol Hematol. 2020. PMID: 32416348
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis.
Cantini L, Pecci F, Murrone A, Tomasetti M, Copparoni C, Fiordoliva I, Morgese F, Rinaldi S, Mazzanti P, Rubini C, Cimadamore A, Barbisan F, Giampieri R, Scarpelli M, Santarelli L, Berardi R. Cantini L, et al. Among authors: fiordoliva i. Lung Cancer. 2020 Aug;146:318-326. doi: 10.1016/j.lungcan.2020.06.024. Epub 2020 Jun 21. Lung Cancer. 2020. PMID: 32622302
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy.
Berardi R, Rinaldi S, Santoni M, Newsom-Davis T, Tiberi M, Morgese F, Caramanti M, Savini A, Ferrini C, Torniai M, Fiordoliva I, Bower M, Cascinu S. Berardi R, et al. Among authors: fiordoliva i. Oncotarget. 2016 May 3;7(18):26916-24. doi: 10.18632/oncotarget.8309. Oncotarget. 2016. PMID: 27029035 Free PMC article.
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma.
Murrone A, Cantini L, Pecci F, Cognigni V, Copparoni C, Rinaldi S, Fiordoliva I, Monaco F, Rubini C, Barbisan F, Cimadamore A, Giampieri R, Bianchi F, Tomasetti M, Amati M, Santarelli L, Berardi R. Murrone A, et al. Among authors: fiordoliva i. J Thorac Dis. 2021 Oct;13(10):5741-5751. doi: 10.21037/jtd-21-555. J Thorac Dis. 2021. PMID: 34795923 Free PMC article.
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma.
Berardi R, Caramanti M, Fiordoliva I, Morgese F, Savini A, Rinaldi S, Torniai M, Tiberi M, Ferrini C, Castagnani M, Rovinelli F, Onofri A, Cascinu S. Berardi R, et al. Among authors: fiordoliva i. Support Care Cancer. 2015 Mar;23(3):621-6. doi: 10.1007/s00520-014-2398-6. Epub 2014 Aug 21. Support Care Cancer. 2015. PMID: 25142706
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases.
Rinaldi S, Santoni M, Leoni G, Fiordoliva I, Marcantognini G, Meletani T, Armento G, Santini D, Newsom-Davis T, Tiberi M, Morgese F, Torniai M, Bower M, Berardi R. Rinaldi S, et al. Among authors: fiordoliva i. Support Care Cancer. 2019 Apr;27(4):1255-1261. doi: 10.1007/s00520-018-4489-2. Epub 2018 Nov 8. Support Care Cancer. 2019. PMID: 30406916
18 results